See prescribing information, including boxed warning. The majority of people with td or chorea associated with huntington disease (hd) who were treated with austedo xr (deutetrabenazine Patients taking austedo xr® (deutetrabenazine) tablets to treat hd chorea saw symptom improvements in 12 weeks
kattpaccino OnlyFans Model Account Profile
See safety info and boxed warning.
Austedo (deutetrabenazine) is a reversible inhibitor of the vesicular monoamine transporter 2 (vmat2) used to treat chorea in huntington's disease and tardive dyskinesia, with a recommended treatment approach based on the american psychiatric association's guidelines for managing tardive dyskinesia associated with antipsychotic therapy 1.